Attached files

file filename
EX-99.1 - EXHIBIT 99.1 PRESS RELEASE - CYTRX CORPexh99-1.htm




SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 10, 2015


CYTRX CORPORATION
(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

000-15327
(Commission File Number)
 
58-1642740
(I.R.S. Employer Identification No.)
11726 San Vicente Boulevard, Suite 650
Los Angeles, California
(Address of Principal Executive Offices)
 
90049
(Zip Code)

(310) 826-5648
(Registrant’s Telephone Number, Including Area Code)

______________________________


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (See General Instruction A.2 below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 


Item 8.01: Other Events.
 
CytRx Corporation on December 10, 2015 issued a press release regarding the reaching of an agreement to settle the consolidated securities class action lawsuit pending in the United States District Court for the Central District of California, titled In re CytRx Corporation Securities Litigation.  A copy of the press release is attached as Exhibit 99.1.
 
Item 9.01.  Financial Statements and Exhibits.
 
The exhibit listed on the accompanying Index to Exhibits is filed herewith.
 


 
 

 

SIGNATURES
 
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
  CYTRX CORPORATION  
       
Date: December 10, 2015
By:
/s/  JOHN Y. CALOZ  
    John Y. Caloz  
    Chief Financial Officer   
       
 

 
 

 

INDEX TO EXHIBITS
 

Exhibit
Description
99.1
Press Release dated December 10, 2015